Our global splicing analysis of blood samples from 17 PD patients and 11 healthy controls showed that SRRM2 has differential exonic expression, with the 5′ exons over-expressed and the 3′ exons down-regulated in PD relative to controls (Figure 3). Here, SRRM2 is linked to Parkinson disease.